Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
75 participants
OBSERVATIONAL
2019-03-29
2020-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Subclinical Enthesitis by Ultrasonography
NCT04209894
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840
Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1
NCT04911283
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
NCT07157189
Aetiology of TemporaL Arteritis Study
NCT02584517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chronic otitis media
patients with chronic otitis media without cholesteatoma
serum for sclerostin ELISA test
Blood sample to measure serum sclerostin level
cholesteatoma
patients with chronic otitis media whose cholesteatoma
serum for sclerostin ELISA test
Blood sample to measure serum sclerostin level
control
patients scheduled to operation with diagnosis of other causes
serum for sclerostin ELISA test
Blood sample to measure serum sclerostin level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
serum for sclerostin ELISA test
Blood sample to measure serum sclerostin level
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozgur Mehmet Yis
Assistant Professor Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Özgür Mehmet Yis
Bolu, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AbantIBU-Biochem-OMY-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.